Updates on NET and Diversity Research With Pamela Kunz

To tackle the complicated world of neuroendocrine tumors (NETs), Chadi is joined by Pamela Kunz (@PamelaKunzMD), MD, Director of the Center for GI Cancers at Yale Cancer Center; as well as the Vice Chief of Diversity, Equity, and Inclusion for medical oncology at Yale Cancer Center. Dr. Kunz begins by shedding light on potential reasons for higher incidence of NETs in the past three decades and the boom of FDA approvals in the last decade, as well as the latest therapies and clinical trials with the most potential to move the needle for patient care. Then, Chadi and Dr. Kunz highlight the priorities of a new committee she has helped form for diversity, equity, and inclusion within the institution – including data collection, increasing the diversity of the faculty, and creating a culture of respect.